Recent Advances in the Treatment of Preterm Newborn Infants with Patent Ductus Arteriosus
Authors:
- 1 March 2016
- journal article
- review article
- Published by Elsevier in Clinics in Perinatology
- Vol. 43 (1) , 113-129
Abstract
No abstract availableKeywords
This publication has 82 references indexed in Scilit:
- Comparison of Oral Paracetamol versus Ibuprofen in Premature Infants with Patent Ductus Arteriosus: A Randomized Controlled TrialPLOS ONE, 2013
- Prenatal and perinatal analgesic exposure and autism: an ecological linkEnvironmental Health, 2013
- Intravenous Paracetamol for Patent Ductus Arteriosus in Premature Infants - A Lower Dose Is Also EffectiveNeonatology, 2013
- Patent Ductus Arteriosus: Are Current Neonatal Treatment Options Better or Worse Than No Treatment at All?Seminars in Perinatology, 2012
- Ductal Closure With Paracetamol: A Surprising New Approach to Patent Ductus Arteriosus TreatmentPediatrics, 2011
- Efficacy and Safety of Oral Versus Intravenous Ibuprofen in Very Low Birth Weight Preterm Infants with Patent Ductus ArteriosusThe Journal of Pediatrics, 2011
- Patent ductus arteriosus in the preterm infant: new insights into pathogenesis and clinical managementThe Journal of Maternal-Fetal & Neonatal Medicine, 2010
- Patent Ductus Arteriosus Therapy: Impact on Neonatal and 18-Month OutcomePediatrics, 2009
- Prevention of intraventricular hemorrhage by indomethacin in male preterm infantsThe Journal of Pediatrics, 2004
- Early echocardiographic prediction of symptomatic patent ductus arteriosus in preterm infants undergoing mechanical ventilationThe Journal of Pediatrics, 1995